Sheri L. Bortz, MD
General Practice · Saratoga
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bortz’s office at (408) 446-4774 to ask if they take your plan before you enroll.
California Medical Board record
Licence G38079 · Current
Licensed to practise in California · since 1978 · expires 2027-11-30 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 153 Part D prescriptions in 2020.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2020 | 153 | 54 | 0% (0) | 8% | $7,678 |
| 2019 | 1,070 | 225 | 1% (11) | None | $67,525 |
| 2018 | 1,017 | 215 | None | None | $59,633 |
| 2017 | 750 | 140 | None | None | $45,134 |
| 2016 | 655 | 114 | 3% (18) | None | $41,027 |
| 2015 | 666 | 97 | 3% (17) | None | $49,398 |
| 2014 | 214 | 55 | 8% (18) | 29% | $15,259 |
| 2013 | 144 | 42 | None | 37% | $14,985 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Atorvastatin | 11 | $168 | $15 |
2019: 29 drugs
| Myrbetriq | 11 | $4,420 | $402 |
| Atorvastatin | 92 | $1,552 | $17 |
| Synthroid | 13 | $1,336 | $103 |
| Levothyroxine | 41 | $1,224 | $30 |
| Rosuvastatin | 21 | $1,175 | $56 |
| Metoprolol | 20 | $1,023 | $51 |
| Escitalopram | 23 | $495 | $22 |
| Olmesartan Medoxomil | 13 | $457 | $35 |
| Metformin | 26 | $443 | $17 |
| Zolpidem | 11 | $420 | $38 |
| Pravastatin | 12 | $413 | $34 |
| Amlodipine Besylate | 52 | $383 | $7 |
| Metoprolol | 28 | $367 | $13 |
| Lisinopril | 32 | $366 | $11 |
| Omeprazole | 15 | $332 | $22 |
| Losartan | 24 | $322 | $13 |
| Alprazolam | 13 | $259 | $20 |
| Hydrochlorothiazide | 26 | $236 | $9 |
| Trazodone | 13 | $229 | $18 |
| Benazepril | 13 | $197 | $15 |
| Montelukast | 16 | $193 | $12 |
| Clonidine | 12 | $183 | $15 |
| Triamterene-Hydrochlorothiazid | 14 | $180 | $13 |
| Lansoprazole | 11 | $145 | $13 |
| Lisinopril-Hydrochlorothiazide | 14 | $123 | $9 |
| Simvastatin | 15 | $122 | $8 |
| Meloxicam | 11 | $93 | $8 |
| Azithromycin | 12 | $90 | $8 |
| Atenolol | 12 | $79 | $7 |
2018: 24 drugs
| Eliquis | 11 | $6,307 | $573 |
| Levothyroxine | 63 | $1,701 | $27 |
| Atorvastatin | 90 | $1,667 | $19 |
| Rosuvastatin | 30 | $1,421 | $47 |
| Metoprolol | 22 | $1,011 | $46 |
| Olmesartan Medoxomil | 22 | $1,009 | $46 |
| Acyclovir | 12 | $517 | $43 |
| Lisinopril | 40 | $434 | $11 |
| Escitalopram | 23 | $366 | $16 |
| Losartan | 22 | $260 | $12 |
| Metoprolol | 15 | $233 | $16 |
| Metformin | 19 | $226 | $12 |
| Alprazolam | 22 | $204 | $9 |
| Triamcinolone Acetonide | 15 | $201 | $13 |
| Amlodipine Besylate | 39 | $188 | $5 |
| Simvastatin | 13 | $179 | $14 |
| Montelukast | 14 | $178 | $13 |
| Omeprazole | 16 | $176 | $11 |
| Tizanidine | 14 | $146 | $10 |
| Hydrochlorothiazide | 22 | $144 | $7 |
| Fluticasone Propionate | 14 | $137 | $10 |
| Lisinopril-Hydrochlorothiazide | 15 | $122 | $8 |
| Atenolol | 11 | $80 | $7 |
| Azithromycin | 12 | $77 | $6 |
2017: 18 drugs
| Olmesartan Medoxomil | 21 | $3,472 | $165 |
| Bystolic | 14 | $1,850 | $132 |
| Atorvastatin | 63 | $1,388 | $22 |
| Levothyroxine | 34 | $941 | $28 |
| Metoprolol | 22 | $925 | $42 |
| Rosuvastatin | 20 | $504 | $25 |
| Escitalopram | 21 | $409 | $19 |
| Metoprolol | 14 | $281 | $20 |
| Metformin | 14 | $223 | $16 |
| Lisinopril | 22 | $206 | $9 |
| Fluticasone Propionate | 13 | $199 | $15 |
| Alprazolam | 23 | $197 | $9 |
| Amlodipine Besylate | 36 | $185 | $5 |
| Montelukast | 11 | $153 | $14 |
| Naproxen | 13 | $84 | $6 |
| Hydrochlorothiazide | 15 | $70 | $5 |
| Lisinopril-Hydrochlorothiazide | 11 | $66 | $6 |
| Losartan | 14 | $61 | $4 |
2016: 10 drugs
| Benicar | 23 | $7,904 | $344 |
| Bystolic | 19 | $2,743 | $144 |
| Atorvastatin | 61 | $1,258 | $21 |
| Levothyroxine | 27 | $940 | $35 |
| Pravastatin | 15 | $501 | $33 |
| Fluticasone Propionate | 17 | $219 | $13 |
| Amlodipine Besylate | 30 | $205 | $7 |
| Alprazolam | 18 | $166 | $9 |
| Lisinopril | 14 | $161 | $12 |
| Tramadol | 11 | $27 | $2 |
2015: 16 drugs
| Benicar | 22 | $6,466 | $294 |
| Bystolic | 13 | $1,591 | $122 |
| Atorvastatin | 51 | $1,357 | $27 |
| Synthroid | 19 | $1,105 | $58 |
| Levothyroxine | 28 | $971 | $35 |
| Pravastatin | 17 | $650 | $38 |
| Bumetanide | 12 | $463 | $39 |
| Metoprolol | 12 | $419 | $35 |
| Amlodipine Besylate | 43 | $267 | $6 |
| Fluticasone Propionate | 20 | $231 | $12 |
| Metformin | 11 | $128 | $12 |
| Azithromycin | 14 | $105 | $7 |
| Lisinopril | 12 | $100 | $8 |
| Hydrochlorothiazide | 13 | $87 | $7 |
| Alprazolam | 13 | $79 | $6 |
| Spironolactone | 11 | $39 | $4 |
2014: 1 drug
| Metformin | 13 | $136 | $10 |
2013: 2 drugs
| Advair Diskus | 11 | $2,739 | $249 |
| Triamterene-Hydrochlorothiazid | 11 | $98 | $9 |
Money from drug and device companies
$265 in 2025
| 2025 | 2 | 2 | None | $265 |
| 2023 | 2 | 2 | None | $214 |
| 2022 | 1 | 1 | None | $117 |
| 2019 | 17 | 37 | None | $989 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| InSightec | Exablate | $143 | 1 payment
|
| Mayne Pharma Commercial | Bijuva | $122 | 1 payment
|
See all 2 published payments
| InSightec | Meals · 2025-08-26 | Exablate | $143 |
| Mayne Pharma Commercial | Meals · 2025-08-20 | Bijuva | $122 |
See earlier years (2023, 2022, 2019)
2023: $214
| AbbVie | Qulipta | $122 | 1 payment
|
| Medtronic | Percept PC Brainsense | $91 | 1 payment
|
2022: $117
| Horizon Therapeutics plc | Tepezza | $117 | 1 payment
|
2019: $989
| Radius Health | Tymlos | $155 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $140 | 2 payments
|
| Pfizer | Eucrisa | $125 | 6 payments
|
| Teva Pharmaceuticals USA | Ajovy | $125 | 1 payment
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $102 | 9 payments
|
| AMAG Pharmaceuticals | Intrarosa | $76 | 4 payments
|
| AbbVie | Creon | $42 | 2 payments
|
| Philips Electronics North America | Reusable Vest | $34 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $30 | 1 payment
|
| Medline Industries | None | $27 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $25 | 1 payment
|
| Lupin | Suprax | $22 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $22 | 1 payment
|
| Lundbeck | Northera | $20 | 1 payment
|
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $16 | 1 payment
|
| Genentech USA | Xofluza | $15 | 1 payment
|
| Sanofi Pasteur | Fluzone High-Dose | $11 | 1 payment
|
Professional record
- NPI
- 1245364397
- Licence
- CA G38079California G38079: Current · expires 2027-11-30
More record details
- Sole proprietor
- No
- Taxonomy
- General practice (208D00000X)
- Mailing address
- 2047 Montecito Ave, Apt. (, Mountain View, CA, 94043
- NPI first listed
- 2007-03-14
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.